Northern Trust
VAXX

Northern Trust’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Northern Trust’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-333,250
Closed -$239K – 4512
2024
Q1 		$239K Sell
333,250
-1,248
-0.4% -$905 ﹤0.01% 3836
2023
Q4 		$284K Sell
334,498
-17,314
-5% -$16.7K ﹤0.01% 3747
2023
Q3 		$482K Buy
351,812
+70
+0% +$152 ﹤0.01% 3530
2023
Q2 		$886K Buy
351,742
+282,408
+407% +$598K ﹤0.01% 3403
2023
Q1 		$157K Buy
69,334
+6,501
+10% +$16.5K ﹤0.01% 3940
2022
Q4 		$88K Hold
62,833
– – ﹤0.01% 4127
2022
Q3 		$124K Buy
+62,833
New +$131K ﹤0.01% 4044

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Northern Trust's VAXX Position: Q2 2024 in Review

Northern Trust sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 333,250 shares — an estimated $239K sold.

Northern Trust first reported a position in VAXX in Q3 2022 and held it in 7 quarters. The position peaked at $886K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Northern Trust reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Northern Trust sold 333,250 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $239K.
  • Northern Trust first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 7 quarters.
  • Northern Trust's Vaxxinity, Inc. Class A Common Stock position peaked at $886K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.